Sanofi
SNY
487 hedge funds and large institutions have $12.1B invested in Sanofi in 2013 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 168 increasing their positions, 168 reducing their positions, and 38 closing their positions.
100% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 38
28% more call options, than puts
Call options by funds: $25.3M | Put options by funds: $19.8M
7% more funds holding
Funds holding: 456 → 487 (+31)
4% more capital invested
Capital invested by funds: $11.6B → $12.1B (+$502M)
0% more repeat investments, than reductions
Existing positions increased: 168 | Existing positions reduced: 168
0.33% less ownership
Funds ownership: 17.33% → 17% (-0.33%)
38% less funds holding in top 10
Funds holding in top 10: 16 → 10 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$83.7M |
| 2 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$60.8M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$58.1M |
| 4 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$35M |
| 5 |
Lazard Asset Management
New York
|
+$27.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Montag & Caldwell
Atlanta,
Georgia
|
-$370M |
| 2 |
O
OppenheimerFunds
New York
|
-$48M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$46.1M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$40.6M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$27.1M |
SNY Hedge Fund Activity: Q4 2013 in Review
487 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2013, worth a combined $12.1B — up 4.3% from $11.6B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new SNY positions and 38 closed out — a net gain of 38 holders — while 168 added to existing stakes and 168 trimmed.
The largest buyer was Boston Partners, adding an estimated $83.7M. The largest seller was Montag & Caldwell, exiting entirely with an estimated $370M sold.
- 487 institutional investors held Sanofi (SNY) as of Q4 2013, up from 456 in Q3 2013.
- Funds reported $12.1B of Sanofi stock for Q4 2013, up 4.3% quarter-over-quarter.
- 76 funds opened new Sanofi positions in Q4 2013 and 38 closed out, a net change of +38 holders.
- The largest Sanofi buyer in Q4 2013 was Boston Partners, an estimated $83.7M added.
- The largest Sanofi seller in Q4 2013 was Montag & Caldwell, an estimated $370M sold.
Based on aggregated 13F filings for Q4 2013.